Joseph R. Cuccia, M.D. Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 1100 S Jackson Hwy, Suite 101, Sheffield, AL 35660 Phone: 256-381-5955 Fax: 256-381-5957 |
Dr. Marie D. Glenn, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 422 Dd Cox Boulevard, Sheffield, AL 35660 Phone: 256-381-9055 Fax: 256-381-6101 |
Paola F Tumminello, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 342 Cox Blvd, Sheffield, AL 35660 Phone: 256-383-4473 Fax: 256-381-5232 |
News Archive
BELLUS Health Inc. reported today its financial results for the second quarter ended June 30, 2010. The Company also announced new initiatives to reduce its annual expenditures ("burn rate") by focusing its efforts on existing products and on supporting current and future strategic partnerships. All currency figures reported in this press release, including comparative figures, are in Canadian dollars, unless otherwise specified.
The American Medical Association (AMA) today adopted new policy to help address the increasing medical student debt burden at its Annual Meeting.
Antibodies are used in a variety of clinical and research situations to examine the structure and function, and distribution of proteins. However, many researchers have found a lack of specificity in the functioning of these antibodies. This means that any work conducted using these antibodies will not yield reliable results.
Cipher Pharmaceuticals Inc. today announced it has licensed the Canadian distribution rights to CF101, a novel chemical entity being developed by Can-Fite Biopharma for moderate to severe plaque psoriasis and rheumatoid arthritis.
A growing body of research leaves no doubt that nanoparticles can transport drugs into cancer cells, but what is less clear is that the drug payload can exit the tiny endosomes that pull nanoparticles into cells.
› Verified 3 days ago